Viewing Study NCT00093405


Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-03-02 @ 9:38 PM
Study NCT ID: NCT00093405
Status: COMPLETED
Last Update Posted: 2013-06-24
First Post: 2004-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent renal cell cancer View
None stage IV renal cell cancer View
None clear cell renal cell carcinoma View